theMednetRegister

Medical Oncology

Neuro-immunology   

Questions discussed in this category

What would be the main indications for opting for biosimilars over an original biologic, outside of insurance barriers?
Are there any instances where you would prefer a biosimilar rather than the reference product? 
2 Answers available
How do you approach DMT choice in a patient with MS with a history of cancer?
Based on this review (Melamed and Lee, PMID 31998289), patients with MS on several DMTs may be at higher risk for certain cancers. How does this play ...
1 Answer available
In women of childbearing age with NMDA encephalitis and normal pelvic imaging, is there a role for oophorectomy for possible microteratoma?
If not, how often do you repeat pelvic imaging?
1 Answer available


Papers discussed in this category

Arthritis & rheumatology (Hoboken, N.J.), 2018-03
The Science Behind Biosimilars: Entering a New Era of Biologic Therapy.

Related Topics in Medical Oncology

Copyright © 2024 theMednet
All Rights Reserved.